title: Liposomal conjugates for drug delivery to the central nervous system.
abstract: Treatments of central nervous system (CNS) diseases often fail due to the blood-brain barrier. Circumvention of this obstacle is crucial for any systemic treatment of such diseases to be effective. One approach to transfer drugs into the brain is the use of colloidal carrier systems-amongst others, liposomes. A prerequisite for successful drug delivery by colloidal carriers to the brain is the modification of their surface, making them invisible to the reticuloendothelial system (RES) and to target them to specific surface epitopes at the blood-brain barrier. This study characterizes liposomes conjugated with cationized bovine serum albumin (cBSA) as transport vectors in vitro in porcine brain capillary endothelial cells (PBCEC) and in vivo in rats using fluorescently labelled liposomes. Experiments with PBCEC showed that sterically stabilized (PEGylated) liposomes without protein as well as liposomes conjugated to native bovine serum albumin (BSA) were not taken up. In contrast, cBSA-liposomes were taken up and appeared to be concentrated in intracellular vesicles. Uptake occurred in a concentration and time dependent manner. Free BSA and free cBSA inhibited uptake. After intravenous application of cBSA-liposomes, confocal fluorescence microscopy of brain cryosections from male Wistar rats showed fluorescence associated with liposomes in brain capillary surrounding tissue after 3, 6 and 24 h, for liposomes with a diameter between 120 and 150 nm, suggesting successful brain delivery of cationized-albumin coupled liposomes.
authors.affiliation: Department of Pharmaceutical Technology and Biopharmacy, Institute of Pharmacy and Molecular Biotechnology, University of Heidelberg, Im Neuenheimer Feld 329, 69120 Heidelberg, Germany. helm@uni-hd.de.
authors.forename: Frieder
authors.initials: F
authors.lastname: Helm
authors.affiliation: Department of Pharmaceutical Technology and Biopharmacy, Institute of Pharmacy and Molecular Biotechnology, University of Heidelberg, Im Neuenheimer Feld 329, 69120 Heidelberg, Germany. gert.fricker@uni-hd.de.
authors.forename: Gert
authors.initials: G
authors.lastname: Fricker
references.citation: FEBS Lett. 1996 May 20;386(2-3):243-6
references.pmid: 8647291
references.citation: Epilepsia. 2001 Oct;42(10):1231-40
references.pmid: 11737157
references.citation: Nat Prod Commun. 2012 Mar;7(3):353-8
references.pmid: 22545410
references.citation: J Biol Chem. 1987 Nov 5;262(31):15214-9
references.pmid: 2959663
references.citation: Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14164-9
references.pmid: 8943078
references.citation: J Control Release. 2011 Sep 25;154(3):290-7
references.pmid: 21640149
references.citation: Anal Biochem. 1986 Nov 15;159(1):138-42
references.pmid: 3812993
references.citation: Anal Biochem. 1983 Jul 1;132(1):68-73
references.pmid: 6353995
references.citation: J Cell Biol. 1994 Dec;127(5):1217-32
references.pmid: 7525606
references.citation: J Drug Target. 2009 Sep;17(8):610-8
references.pmid: 19694613
references.citation: J Drug Target. 2002 Jun;10(4):337-44
references.pmid: 12164382
references.citation: Brain Res Brain Res Protoc. 2000 Jul;5(3):248-56
references.pmid: 10906490
references.citation: Eur J Pharm Biopharm. 2009 Feb;71(2):251-6
references.pmid: 18805484
references.citation: J Control Release. 2008 Jan 4;125(1):16-24
references.pmid: 18023907
references.citation: Biochim Biophys Acta. 2002 Aug 31;1564(2):343-8
references.pmid: 12175916
references.citation: Arch Biochem Biophys. 1959 May;82(1):70-7
references.pmid: 13650640
references.citation: J Pharmacol Exp Ther. 1990 Nov;255(2):893-9
references.pmid: 2243356
references.citation: J Pharmacol Exp Ther. 2006 Jun;317(3):1246-53
references.pmid: 16554356
references.citation: J Biol Chem. 1967 May 25;242(10):2447-53
references.pmid: 6026234
references.citation: J Pharm Pharmacol. 2007 Apr;59(4):469-83
references.pmid: 17430630
references.citation: J Drug Target. 2000;8(6):435-46
references.pmid: 11328669
references.citation: Methods Mol Biol. 2010;605:29-50
references.pmid: 20072871
references.citation: Anal Biochem. 1979 Dec;100(2):201-20
references.pmid: 393128
references.citation: Science. 1995 Mar 3;267(5202):1275-6
references.pmid: 7871422
references.citation: Pharm Res. 2000 Jun;17(6):749-53
references.pmid: 10955852
references.citation: J Biol Chem. 1980 Feb 25;255(4):1239-41
references.pmid: 6243633
references.citation: Drug Dev Ind Pharm. 2013 Feb;39(2):197-204
references.pmid: 22443684
references.citation: J Mol Biol. 1965 Aug;13(1):238-52
references.pmid: 5859039